Benjamin Prudon
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- Pleural and Pulmonary Diseases 3
- Respiratory and Cough-Related Research 3
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Surinder Singh Birring (3 shared papers)Ian Douglas Pavord (3 shared papers)Sérgio Matos (1 shared paper)Andrew P. Hall (1 shared paper)Jonathan P. Thompson (1 shared paper)Dhiraj D. Vara (1 shared paper)Jonathan Grigg (1 shared paper)Sophie D. West (3 shared papers)
- Journals
- European Respiratory Journal (4 papers)The Lancet (3 papers)Sleep Medicine (2 papers)Respiratory Medicine (1 paper)Movement Disorders (1 paper)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
Benjamin Prudon
15 papers receiving 1.7k citations
Benjamin Prudon's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 870
- Applied Microbiology and Biotechnology 38
- Pulmonary and Respiratory Medicine 474
- Internal Medicine 27
- Statistics and Probability 42
Countries citing papers authored by Benjamin Prudon
This map shows the geographic impact of Benjamin Prudon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Prudon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Prudon more than expected).
Fields of papers citing papers by Benjamin Prudon
This network shows the impact of papers produced by Benjamin Prudon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Prudon. The network helps show where Benjamin Prudon may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Prudon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 526 | |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | 2021 | 213 | |
| 4 | 2005 | 145 | |
| 5 | 2005 | 124 | |
| 6 | 2019 | 98 | |
| 7 | 2004 | 56 | |
| 8 | 2004 | 51 | |
| 9 | 2013 | 37 | |
| 10 | 2021 | 28 | |
| 11 | 2013 | 18 | |
| 12 | 2018 | 17 | |
| 13 | 2023 | 16 | |
| 14 | 2017 | 6 | |
| 15 | 2024 | 6 | |
| 16 | 2025 | 0 |
About Benjamin Prudon
Benjamin Prudon is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Physiology, Pollution and Neurology, having authored 16 papers that have together received 1.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Pleural and Pulmonary Diseases (3 papers), Obstructive Sleep Apnea Research (3 papers), Respiratory and Cough-Related Research (3 papers), Sleep and related disorders (1 paper), Energy and Environment Impacts (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper) and Air Quality and Health Impacts (1 paper). The work is most often cited by research in Infectious Diseases (870 citations), Applied Microbiology and Biotechnology (38 citations), Pulmonary and Respiratory Medicine (474 citations), Internal Medicine (27 citations) and Statistics and Probability (42 citations). Benjamin Prudon has collaborated with scholars based in United Kingdom, Australia and Vietnam. Frequent co-authors include Surinder Singh Birring, Ian Douglas Pavord, Sérgio Matos, Andrew P. Hall, Jonathan P. Thompson, Dhiraj D. Vara, Jonathan Grigg, Sophie D. West, George E Murty and John R. Stradling. Their work appears in journals such as European Respiratory Journal, The Lancet, Sleep Medicine, Respiratory Medicine and Movement Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.